{"body": "NEW YORK, Sept 25 The S&P 500 and Nasdaq turned\nlower in afternoon trading, dragged down by a drop in biotech\nshares.\nThe Nasdaq Biotech Index was down 6.2 percent, led\nlower by a 5.6 percent drop in Celgene.\nThe biotech index is on track for a 14-percent loss for the\nweek. On Monday, U.S. Democratic presidential candidate Hillary\nClinton said she would announce a plan to stop \"price gouging\"\nfor specialty drugs, sparking a fall in the shares.\nAt 2:52 p.m., the Dow Jones industrial average rose\n68.62 points, or 0.42 percent, to 16,269.94, the S&P 500 \nlost 4.54 points, or 0.23 percent, to 1,927.7 and the Nasdaq\nComposite dropped 56.05 points, or 1.18 percent, to\n4,678.43.\n\n\n (Reporting by Caroline Valetkevitch; Editing by Nick Zieminski)", "byline": "", "description": "NEW YORK, Sept 25 (Reuters) - The S&P 500 and Nasdaq turned lower in afternoon trading, dragged down by a drop in biotech shares.", "title": "US STOCKS SNAPSHOT-S&P 500, Nasdaq turn lower; biotechs plunge", "url": "http://feeds.reuters.com/~r/news/usmarkets/~3/8k8Rkhg4fh0/story01.htm", "topics": ["economy"], "people": ["Caroline Valetkevitch", "Nick Zieminski"], "orgs": ["Celgene", "S&P"], "authors": [{"author_id": 33346, "fullname": "reuters editorial", "primary_org": "reuters"}], "date_written": "2015-09-25 19:56:12", "org": "reuters", "article_id": "15eafa017850205b67ba580eff36cced", "date_access": "2015-09-25 19:35:55.333907"}